New Insight into the Central Benzodiazepine Receptor–Ligand Interactions: Design, Synthesis, Biological Evaluation, and Molecular Modeling of 3-Substituted 6-Phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and Related Compounds

3-Substituted 6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and related compounds were synthesized as central benzodiazepine receptor (CBR) ligands. Most of the compounds showed high affinity for bovine and human CBR, their K i values spanning from the low nanomolar to the submicromolar range. In p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2011-08, Vol.54 (16), p.5694-5711
Hauptverfasser: Anzini, Maurizio, Valenti, Salvatore, Braile, Carlo, Cappelli, Andrea, Vomero, Salvatore, Alcaro, Stefano, Ortuso, Francesco, Marinelli, Luciana, Limongelli, Vittorio, Novellino, Ettore, Betti, Laura, Giannaccini, Gino, Lucacchini, Antonio, Daniele, Simona, Martini, Claudia, Ghelardini, Carla, Di Cesare Mannelli, Lorenzo, Giorgi, Gianluca, Mascia, Maria Paola, Biggio, Giovanni
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5711
container_issue 16
container_start_page 5694
container_title Journal of medicinal chemistry
container_volume 54
creator Anzini, Maurizio
Valenti, Salvatore
Braile, Carlo
Cappelli, Andrea
Vomero, Salvatore
Alcaro, Stefano
Ortuso, Francesco
Marinelli, Luciana
Limongelli, Vittorio
Novellino, Ettore
Betti, Laura
Giannaccini, Gino
Lucacchini, Antonio
Daniele, Simona
Martini, Claudia
Ghelardini, Carla
Di Cesare Mannelli, Lorenzo
Giorgi, Gianluca
Mascia, Maria Paola
Biggio, Giovanni
description 3-Substituted 6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and related compounds were synthesized as central benzodiazepine receptor (CBR) ligands. Most of the compounds showed high affinity for bovine and human CBR, their K i values spanning from the low nanomolar to the submicromolar range. In particular, imidazoester 5f was able to promote a massive flow of 36Cl– in rat cerebrocortical synaptoneurosomes overlapping its efficacy profile with that of a typical full agonist. Compound 5f was then examined in mice for its pharmacological effects where it proved to be a safe anxiolytic agent devoid of the unpleasant myorelaxant and amnesic effects of the classical 1,4-benzodiazepines. Moreover, the selectivity of some selected compounds has been assessed in recombinant α1β2γ2L, α2β1γ2L, and α5β2γ2L human GABAA receptors. Finally, some compounds were submitted to molecular docking calculations along with molecular dynamics simulations in the Cromer’s GABAA homology model.
doi_str_mv 10.1021/jm2001597
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_884424188</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>884424188</sourcerecordid><originalsourceid>FETCH-LOGICAL-a170t-d2a2dfbd57af10419e8c2ad4690c3d99265277d61d81e391dd480ab2591d34433</originalsourceid><addsrcrecordid>eNpVkctuEzEUhi0EoqGw4AWQN4hNDL7NjV0bCq0ULmphhaqRZ3ySOPLYw9gGJSvegTfsk-DQgsTqnMX3fzo6P0JPGX3JKGevtgOnlBVNdQ_NWMEpkTWV99GMUs4JL7k4Qo9C2FJKBePiITrirCpYzYoZuvkAP_CFC2a9idi46HHcAF6Ai5Oy-BTc3muj9jAaB_gSehijn25-_lqatXI6JyNMqo_Gu_Aav4HscXN8tXPZEkyY41PjrV-bPsvOviub1AGd40P2vbfQJ6umvGmwxq2xX2FBrlIXookpgsYl-bQBt7NEnhMzGK32_iubF0Rd5yGvu__uC3-0l2DVIbrww-iT0-ExerBSNsCTu3mMvrw9-7w4J8uP7y4WJ0uiWEUj0Vxxvep0UakVo5I1UPdcaVk2tBe6aXhZ8KrSJdM1A9EwrfOXVceLvAophThGL2694-S_JQixHUzowVrlwKfQ1rWUXLK6zuSzOzJ1A-h2nMygpl37t5YMPL8FVB_arU-Ty4e3jLaHutt_dYvfDs-d1A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>884424188</pqid></control><display><type>article</type><title>New Insight into the Central Benzodiazepine Receptor–Ligand Interactions: Design, Synthesis, Biological Evaluation, and Molecular Modeling of 3-Substituted 6-Phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and Related Compounds</title><source>MEDLINE</source><source>ACS Publications</source><creator>Anzini, Maurizio ; Valenti, Salvatore ; Braile, Carlo ; Cappelli, Andrea ; Vomero, Salvatore ; Alcaro, Stefano ; Ortuso, Francesco ; Marinelli, Luciana ; Limongelli, Vittorio ; Novellino, Ettore ; Betti, Laura ; Giannaccini, Gino ; Lucacchini, Antonio ; Daniele, Simona ; Martini, Claudia ; Ghelardini, Carla ; Di Cesare Mannelli, Lorenzo ; Giorgi, Gianluca ; Mascia, Maria Paola ; Biggio, Giovanni</creator><creatorcontrib>Anzini, Maurizio ; Valenti, Salvatore ; Braile, Carlo ; Cappelli, Andrea ; Vomero, Salvatore ; Alcaro, Stefano ; Ortuso, Francesco ; Marinelli, Luciana ; Limongelli, Vittorio ; Novellino, Ettore ; Betti, Laura ; Giannaccini, Gino ; Lucacchini, Antonio ; Daniele, Simona ; Martini, Claudia ; Ghelardini, Carla ; Di Cesare Mannelli, Lorenzo ; Giorgi, Gianluca ; Mascia, Maria Paola ; Biggio, Giovanni</creatorcontrib><description>3-Substituted 6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and related compounds were synthesized as central benzodiazepine receptor (CBR) ligands. Most of the compounds showed high affinity for bovine and human CBR, their K i values spanning from the low nanomolar to the submicromolar range. In particular, imidazoester 5f was able to promote a massive flow of 36Cl– in rat cerebrocortical synaptoneurosomes overlapping its efficacy profile with that of a typical full agonist. Compound 5f was then examined in mice for its pharmacological effects where it proved to be a safe anxiolytic agent devoid of the unpleasant myorelaxant and amnesic effects of the classical 1,4-benzodiazepines. Moreover, the selectivity of some selected compounds has been assessed in recombinant α1β2γ2L, α2β1γ2L, and α5β2γ2L human GABAA receptors. Finally, some compounds were submitted to molecular docking calculations along with molecular dynamics simulations in the Cromer’s GABAA homology model.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm2001597</identifier><identifier>PMID: 21751815</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Animals ; Benzodiazepines - chemistry ; Benzodiazepines - metabolism ; Benzodiazepines - pharmacology ; Binding Sites ; Binding, Competitive - drug effects ; Cattle ; Cerebral Cortex - drug effects ; Cerebral Cortex - metabolism ; Chlorides - pharmacokinetics ; Flumazenil - metabolism ; HEK293 Cells ; Humans ; Ligands ; Male ; Mice ; Models, Molecular ; Molecular Structure ; Motor Activity - drug effects ; Protein Structure, Tertiary ; Protein Subunits - chemistry ; Protein Subunits - genetics ; Protein Subunits - metabolism ; Radioligand Assay ; Receptors, GABA-A - chemistry ; Receptors, GABA-A - genetics ; Receptors, GABA-A - metabolism ; Synaptosomes - drug effects ; Synaptosomes - metabolism ; Tritium ; Xenopus laevis</subject><ispartof>Journal of medicinal chemistry, 2011-08, Vol.54 (16), p.5694-5711</ispartof><rights>Copyright © 2011 American Chemical Society</rights><rights>2011 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm2001597$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm2001597$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21751815$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anzini, Maurizio</creatorcontrib><creatorcontrib>Valenti, Salvatore</creatorcontrib><creatorcontrib>Braile, Carlo</creatorcontrib><creatorcontrib>Cappelli, Andrea</creatorcontrib><creatorcontrib>Vomero, Salvatore</creatorcontrib><creatorcontrib>Alcaro, Stefano</creatorcontrib><creatorcontrib>Ortuso, Francesco</creatorcontrib><creatorcontrib>Marinelli, Luciana</creatorcontrib><creatorcontrib>Limongelli, Vittorio</creatorcontrib><creatorcontrib>Novellino, Ettore</creatorcontrib><creatorcontrib>Betti, Laura</creatorcontrib><creatorcontrib>Giannaccini, Gino</creatorcontrib><creatorcontrib>Lucacchini, Antonio</creatorcontrib><creatorcontrib>Daniele, Simona</creatorcontrib><creatorcontrib>Martini, Claudia</creatorcontrib><creatorcontrib>Ghelardini, Carla</creatorcontrib><creatorcontrib>Di Cesare Mannelli, Lorenzo</creatorcontrib><creatorcontrib>Giorgi, Gianluca</creatorcontrib><creatorcontrib>Mascia, Maria Paola</creatorcontrib><creatorcontrib>Biggio, Giovanni</creatorcontrib><title>New Insight into the Central Benzodiazepine Receptor–Ligand Interactions: Design, Synthesis, Biological Evaluation, and Molecular Modeling of 3-Substituted 6-Phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and Related Compounds</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>3-Substituted 6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and related compounds were synthesized as central benzodiazepine receptor (CBR) ligands. Most of the compounds showed high affinity for bovine and human CBR, their K i values spanning from the low nanomolar to the submicromolar range. In particular, imidazoester 5f was able to promote a massive flow of 36Cl– in rat cerebrocortical synaptoneurosomes overlapping its efficacy profile with that of a typical full agonist. Compound 5f was then examined in mice for its pharmacological effects where it proved to be a safe anxiolytic agent devoid of the unpleasant myorelaxant and amnesic effects of the classical 1,4-benzodiazepines. Moreover, the selectivity of some selected compounds has been assessed in recombinant α1β2γ2L, α2β1γ2L, and α5β2γ2L human GABAA receptors. Finally, some compounds were submitted to molecular docking calculations along with molecular dynamics simulations in the Cromer’s GABAA homology model.</description><subject>Animals</subject><subject>Benzodiazepines - chemistry</subject><subject>Benzodiazepines - metabolism</subject><subject>Benzodiazepines - pharmacology</subject><subject>Binding Sites</subject><subject>Binding, Competitive - drug effects</subject><subject>Cattle</subject><subject>Cerebral Cortex - drug effects</subject><subject>Cerebral Cortex - metabolism</subject><subject>Chlorides - pharmacokinetics</subject><subject>Flumazenil - metabolism</subject><subject>HEK293 Cells</subject><subject>Humans</subject><subject>Ligands</subject><subject>Male</subject><subject>Mice</subject><subject>Models, Molecular</subject><subject>Molecular Structure</subject><subject>Motor Activity - drug effects</subject><subject>Protein Structure, Tertiary</subject><subject>Protein Subunits - chemistry</subject><subject>Protein Subunits - genetics</subject><subject>Protein Subunits - metabolism</subject><subject>Radioligand Assay</subject><subject>Receptors, GABA-A - chemistry</subject><subject>Receptors, GABA-A - genetics</subject><subject>Receptors, GABA-A - metabolism</subject><subject>Synaptosomes - drug effects</subject><subject>Synaptosomes - metabolism</subject><subject>Tritium</subject><subject>Xenopus laevis</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkctuEzEUhi0EoqGw4AWQN4hNDL7NjV0bCq0ULmphhaqRZ3ySOPLYw9gGJSvegTfsk-DQgsTqnMX3fzo6P0JPGX3JKGevtgOnlBVNdQ_NWMEpkTWV99GMUs4JL7k4Qo9C2FJKBePiITrirCpYzYoZuvkAP_CFC2a9idi46HHcAF6Ai5Oy-BTc3muj9jAaB_gSehijn25-_lqatXI6JyNMqo_Gu_Aav4HscXN8tXPZEkyY41PjrV-bPsvOviub1AGd40P2vbfQJ6umvGmwxq2xX2FBrlIXookpgsYl-bQBt7NEnhMzGK32_iubF0Rd5yGvu__uC3-0l2DVIbrww-iT0-ExerBSNsCTu3mMvrw9-7w4J8uP7y4WJ0uiWEUj0Vxxvep0UakVo5I1UPdcaVk2tBe6aXhZ8KrSJdM1A9EwrfOXVceLvAophThGL2694-S_JQixHUzowVrlwKfQ1rWUXLK6zuSzOzJ1A-h2nMygpl37t5YMPL8FVB_arU-Ty4e3jLaHutt_dYvfDs-d1A</recordid><startdate>20110825</startdate><enddate>20110825</enddate><creator>Anzini, Maurizio</creator><creator>Valenti, Salvatore</creator><creator>Braile, Carlo</creator><creator>Cappelli, Andrea</creator><creator>Vomero, Salvatore</creator><creator>Alcaro, Stefano</creator><creator>Ortuso, Francesco</creator><creator>Marinelli, Luciana</creator><creator>Limongelli, Vittorio</creator><creator>Novellino, Ettore</creator><creator>Betti, Laura</creator><creator>Giannaccini, Gino</creator><creator>Lucacchini, Antonio</creator><creator>Daniele, Simona</creator><creator>Martini, Claudia</creator><creator>Ghelardini, Carla</creator><creator>Di Cesare Mannelli, Lorenzo</creator><creator>Giorgi, Gianluca</creator><creator>Mascia, Maria Paola</creator><creator>Biggio, Giovanni</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20110825</creationdate><title>New Insight into the Central Benzodiazepine Receptor–Ligand Interactions: Design, Synthesis, Biological Evaluation, and Molecular Modeling of 3-Substituted 6-Phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and Related Compounds</title><author>Anzini, Maurizio ; Valenti, Salvatore ; Braile, Carlo ; Cappelli, Andrea ; Vomero, Salvatore ; Alcaro, Stefano ; Ortuso, Francesco ; Marinelli, Luciana ; Limongelli, Vittorio ; Novellino, Ettore ; Betti, Laura ; Giannaccini, Gino ; Lucacchini, Antonio ; Daniele, Simona ; Martini, Claudia ; Ghelardini, Carla ; Di Cesare Mannelli, Lorenzo ; Giorgi, Gianluca ; Mascia, Maria Paola ; Biggio, Giovanni</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a170t-d2a2dfbd57af10419e8c2ad4690c3d99265277d61d81e391dd480ab2591d34433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Benzodiazepines - chemistry</topic><topic>Benzodiazepines - metabolism</topic><topic>Benzodiazepines - pharmacology</topic><topic>Binding Sites</topic><topic>Binding, Competitive - drug effects</topic><topic>Cattle</topic><topic>Cerebral Cortex - drug effects</topic><topic>Cerebral Cortex - metabolism</topic><topic>Chlorides - pharmacokinetics</topic><topic>Flumazenil - metabolism</topic><topic>HEK293 Cells</topic><topic>Humans</topic><topic>Ligands</topic><topic>Male</topic><topic>Mice</topic><topic>Models, Molecular</topic><topic>Molecular Structure</topic><topic>Motor Activity - drug effects</topic><topic>Protein Structure, Tertiary</topic><topic>Protein Subunits - chemistry</topic><topic>Protein Subunits - genetics</topic><topic>Protein Subunits - metabolism</topic><topic>Radioligand Assay</topic><topic>Receptors, GABA-A - chemistry</topic><topic>Receptors, GABA-A - genetics</topic><topic>Receptors, GABA-A - metabolism</topic><topic>Synaptosomes - drug effects</topic><topic>Synaptosomes - metabolism</topic><topic>Tritium</topic><topic>Xenopus laevis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anzini, Maurizio</creatorcontrib><creatorcontrib>Valenti, Salvatore</creatorcontrib><creatorcontrib>Braile, Carlo</creatorcontrib><creatorcontrib>Cappelli, Andrea</creatorcontrib><creatorcontrib>Vomero, Salvatore</creatorcontrib><creatorcontrib>Alcaro, Stefano</creatorcontrib><creatorcontrib>Ortuso, Francesco</creatorcontrib><creatorcontrib>Marinelli, Luciana</creatorcontrib><creatorcontrib>Limongelli, Vittorio</creatorcontrib><creatorcontrib>Novellino, Ettore</creatorcontrib><creatorcontrib>Betti, Laura</creatorcontrib><creatorcontrib>Giannaccini, Gino</creatorcontrib><creatorcontrib>Lucacchini, Antonio</creatorcontrib><creatorcontrib>Daniele, Simona</creatorcontrib><creatorcontrib>Martini, Claudia</creatorcontrib><creatorcontrib>Ghelardini, Carla</creatorcontrib><creatorcontrib>Di Cesare Mannelli, Lorenzo</creatorcontrib><creatorcontrib>Giorgi, Gianluca</creatorcontrib><creatorcontrib>Mascia, Maria Paola</creatorcontrib><creatorcontrib>Biggio, Giovanni</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anzini, Maurizio</au><au>Valenti, Salvatore</au><au>Braile, Carlo</au><au>Cappelli, Andrea</au><au>Vomero, Salvatore</au><au>Alcaro, Stefano</au><au>Ortuso, Francesco</au><au>Marinelli, Luciana</au><au>Limongelli, Vittorio</au><au>Novellino, Ettore</au><au>Betti, Laura</au><au>Giannaccini, Gino</au><au>Lucacchini, Antonio</au><au>Daniele, Simona</au><au>Martini, Claudia</au><au>Ghelardini, Carla</au><au>Di Cesare Mannelli, Lorenzo</au><au>Giorgi, Gianluca</au><au>Mascia, Maria Paola</au><au>Biggio, Giovanni</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>New Insight into the Central Benzodiazepine Receptor–Ligand Interactions: Design, Synthesis, Biological Evaluation, and Molecular Modeling of 3-Substituted 6-Phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and Related Compounds</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2011-08-25</date><risdate>2011</risdate><volume>54</volume><issue>16</issue><spage>5694</spage><epage>5711</epage><pages>5694-5711</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>3-Substituted 6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and related compounds were synthesized as central benzodiazepine receptor (CBR) ligands. Most of the compounds showed high affinity for bovine and human CBR, their K i values spanning from the low nanomolar to the submicromolar range. In particular, imidazoester 5f was able to promote a massive flow of 36Cl– in rat cerebrocortical synaptoneurosomes overlapping its efficacy profile with that of a typical full agonist. Compound 5f was then examined in mice for its pharmacological effects where it proved to be a safe anxiolytic agent devoid of the unpleasant myorelaxant and amnesic effects of the classical 1,4-benzodiazepines. Moreover, the selectivity of some selected compounds has been assessed in recombinant α1β2γ2L, α2β1γ2L, and α5β2γ2L human GABAA receptors. Finally, some compounds were submitted to molecular docking calculations along with molecular dynamics simulations in the Cromer’s GABAA homology model.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>21751815</pmid><doi>10.1021/jm2001597</doi><tpages>18</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2011-08, Vol.54 (16), p.5694-5711
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_884424188
source MEDLINE; ACS Publications
subjects Animals
Benzodiazepines - chemistry
Benzodiazepines - metabolism
Benzodiazepines - pharmacology
Binding Sites
Binding, Competitive - drug effects
Cattle
Cerebral Cortex - drug effects
Cerebral Cortex - metabolism
Chlorides - pharmacokinetics
Flumazenil - metabolism
HEK293 Cells
Humans
Ligands
Male
Mice
Models, Molecular
Molecular Structure
Motor Activity - drug effects
Protein Structure, Tertiary
Protein Subunits - chemistry
Protein Subunits - genetics
Protein Subunits - metabolism
Radioligand Assay
Receptors, GABA-A - chemistry
Receptors, GABA-A - genetics
Receptors, GABA-A - metabolism
Synaptosomes - drug effects
Synaptosomes - metabolism
Tritium
Xenopus laevis
title New Insight into the Central Benzodiazepine Receptor–Ligand Interactions: Design, Synthesis, Biological Evaluation, and Molecular Modeling of 3-Substituted 6-Phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and Related Compounds
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T12%3A52%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=New%20Insight%20into%20the%20Central%20Benzodiazepine%20Receptor%E2%80%93Ligand%20Interactions:%20Design,%20Synthesis,%20Biological%20Evaluation,%20and%20Molecular%20Modeling%20of%203-Substituted%206-Phenyl-4H-imidazo%5B1,5-a%5D%5B1,4%5Dbenzodiazepines%20and%20Related%20Compounds&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Anzini,%20Maurizio&rft.date=2011-08-25&rft.volume=54&rft.issue=16&rft.spage=5694&rft.epage=5711&rft.pages=5694-5711&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/jm2001597&rft_dat=%3Cproquest_pubme%3E884424188%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=884424188&rft_id=info:pmid/21751815&rfr_iscdi=true